VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
QIPTQuipt Home Medical Corp.
$3.65$161M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksQIPTCash Flow

Quipt Home Medical Corp. (QIPT) Cash Flow Statement

27Y historyFree accessUpdated daily

Despite reporting positive operating cash flow, the company faces liquidity pressure from working capital volatility, including a $4.0 million cash outflow in 2026Q1, and inconsistent free cash flow margins that dropped to 5.6% in 2025Q3.

QIPT Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMSep'25Sep'24Sep'23Sep'22Sep'21Sep'20Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Jun'09Jun'08Jun'07Jun'06Jun'05Jun'04Jun'03Jun'02Jun'01Jun'00Jun'99
Cash from Operations37.47M37.69M35.38M36.98M26.34M17.76M9.89M8.39M10.64M-6.07M-4.46M-2.38M-1.17M214.32K-1.12M-1.5M-1.13M-302.23K-94.06K987.89K158.53K-468.41K-66.03K-11.3K78.92K-38.07K-171.14K28.07K
Operating CF Margin %-15.36%14.39%17.47%18.84%17.35%13.52%13.72%19.5%-9.86%-4.63%-4.46%-6.16%5.56%-28.32%-108.08%-2986.55%-19.31%-4.25%16.76%2.83%-10.18%-1.1%-0.27%2.45%-1.96%-43.81%-
Operating CF Growth %95.29%6.53%-4.32%40.37%48.33%79.52%17.92%-21.18%275.42%-36.03%-87.35%-103.43%-646.1%119.1%25.36%-32.47%-275.51%-221.3%-109.52%523.16%133.84%-609.44%-484.29%-114.32%307.3%77.76%-709.65%-
Net Income-10.74M-10.7M-6.76M-3.78M6.68M-6.17M-3.79M-5.58M-5.39M-19.15M-57.37M-18.32M-1.4M-2.47M-548K-1.53M-1.59M-3.93K-1.55M156.59K-208.27K-710.13K-1.25M-41.54K-156.37K-336.47K-241.26K-34.05K
Depreciation & Amortization52.13M51.92M50.55M41.23M23.04M17.73M10.98M10.55M12.02M12.45M22.18M8.67M2.21M386.02K297.84K116.82K7.42K33.73K47.51K236.5K217.27K177.09K186.96K166.92K135.54K130.89K77.87K263
Stock-Based Compensation4.81M4.04M2.48M5.28M7.59M4.95M128.44K1.56M1.29M-1.21M7.92M6.83M1.32M63.21K70.55K136.33K212.6K00000000000
Deferred Taxes83K85K342K-548K0-3.8M4.96M4.3M4.06M0-8.15M621.15K-1.08M2.8M016.68K-97.1K056.1K-123.25K086.28K18K00000
Other Non-Cash Items-4.76M-6.56M-3.54M-3.19M-11.72M13.9M1.12M1.39M3.04M6.04M55.19M14.02M2.1M94.4K95.91K-36.47K25.44K-464.99K1.02M420.98K-20.18K112.8K827.3K-47.06K8.24K5.95K5.31K1.71K
Working Capital Changes-4.13M-1.08M-7.7M-2.01M758K-8.85M-3.5M-3.82M-4.38M-4.2M-24.24M-14.19M-4.32M-658.65K-1.04M-204.34K311.73K132.96K329.74K297.08K169.7K-134.45K156.38K-89.62K91.5K161.56K-13.06K60.15K
Change in Receivables991.21K2.58M-3.29M-3.06M-201K-8.82M-3.86M-5.16M-7M-4.21M-19.74M-7.38M-4.09M-428.24K-455.73K-386.57K-33.59K-28.83K-19.92K83.01K-34.43K0-155K00000
Change in Inventory-4.45M-2.42M-3.42M-60K-2.42M-44K-1.33M637.56K3.69M-3.98M176.46K-1.64M-272.97K-266.05K57.26K-66.59K-13.69K0000000-5.66K000
Change in Payables-1.63M-3.41M3.13M3.12M3.35M518K1.66M0-4.12M0-3.75M-4.7M-539.91K000000000000000
Cash from Investing-31.27M-32.95M-10.31M-82.83M-42.49M-17.84M-5.93M1.77M-723.68K9.3M-22.93M-35.45M-3.08M-395.14K-663.73K-661.64K-161.01K563.62K-41.28K-313.24K-6.57K-21.32K-896.84K-100.83K-348.36K-11.55K-105.57K-68.08K
Capital Expenditures-10.75M-12.35M-10.31M-6.85M-9.16M-5.05M-69.02K-1.36M-530.18K-2.44M-2.94M-5.58M-1.2M-91.36K-738.54K-661.64K-129.52K-1.22K-1.48K-120.03K-6.57K-21.32K-200.83K-83.91K-111.78K-8.58K-154.69K0
CapEx % of Revenue3.75%5.04%4.19%3.24%6.55%4.93%0.09%2.23%0.97%3.97%3.05%10.45%6.34%2.37%18.64%47.57%340.83%0.08%0.07%2.04%0.12%0.46%3.36%1.99%3.47%0.44%39.6%-
Acquisitions0-21.82M-210K-76.04M-33.52M-12.89M-6.05M2.97M-422.6K-129.78K-19.99M-29.87M-1.88M-303.79K00000-193.21K00-680.88K0-18.52K-38.1K-33.76K0
Investments----------------------------
Other Investing-20.53M1.23M210K65K193K98K190.79K161.66K229.1K11.87M000074.81K0-31.49K564.84K-39.8K000-15.13K-16.93K-218.05K00-31.43K
Cash from Financing-11.82M-7.76M-26.15M54.43M-9.85M4.84M10.48M-5.03M-10.51M-6.53M-6.54M60.16M13.6M3.2M1.42M04.06M-291.25K-27.68K-443.52K-103.15K-100.16K1.33M77.43K472.04K84.38K225.74K19.33K
Debt Issued (Net)-11.85M-7.58M-25.5M27.22M-5.07M-12.96M-6.96M-8.92M-10.89M-1.79M-3.15M-740.41K5.73M3.2M720.05K00-435.08K-8.26K329.69K-47.58K-143.77K628.51K-56.44K3.42K-58.9K-9.92K0
Equity Issued (Net)508.15K-130.5K357.03K1000K523.47K1000K1000K1000K252K4K01000K1000K0685.88K01000K227.21K235.8K0113.81K114.3K702.26K155.84K366.83K143.28K235.66K19.33K
Dividends Paid0000000000000000000000000000
Share Repurchases-130.52K-130.5K-214.22K000000000000000000-7.1K000000
Other Financing-476.95K-49.35K-1.01M-653.79K-5.3M-1.21M-1.75M756.65K123.7K-4.75M-3.38M14.84M2.44M011.52K057.89K-83.38K-255.22K-773.2K-169.38K-70.69K0-21.98K101.79K000
Net Change in Cash-4.91M-3.26M-1.03M8.69M-26.1M5.38M14.66M6.44M727.55K-2.74M-34.35M28.23M9.58M3.02M-362.21K-2.19M2.79M-29.86K-163.03K231.13K48.81K-589.88K367.91K-34.71K202.6K34.76K-50.97K-20.68K
Free Cash Flow26.69M25.34M25.07M30.13M17.18M13.65M9.82M7.03M10.11M-7.33M-7.4M-7.96M-2.37M122.97K-1.86M-2.17M-1.26M-303.45K-95.54K867.86K151.96K-489.72K-266.85K-95.21K-32.87K-46.65K-325.83K28.07K
FCF Margin %9.31%10.33%10.19%14.23%12.29%13.33%13.43%11.49%18.53%-11.91%-7.68%-14.9%-12.51%3.19%-46.95%-155.64%-3327.38%-19.38%-4.32%14.73%2.71%-10.65%-4.47%-2.26%-1.02%-2.4%-83.41%-
FCF Growth %17.33%1.08%-16.79%75.34%25.92%38.9%39.79%-30.51%237.93%0.92%7.02%-235.18%-2031.26%106.61%14.06%-71.23%-316.68%-217.6%-111.01%471.12%131.03%-83.52%-180.28%-189.7%29.55%85.68%-1260.74%-
FCF per Share0.610.590.590.760.460.450.430.340.50-0.39-0.42-0.69-0.370.04-0.58-0.72-0.59-5.55-1.5313.672.16-6.12-4.03-8.19-4.16-9.16-82.0511.18
FCF Conversion (FCF/Net Income)-2.49x-3.52x-5.23x-13.28x5.44x-2.88x-2.16x-1.50x0.73x0.32x0.08x0.13x0.83x-0.08x2.05x0.95x0.71x-0.24x0.05x1.38x-0.54x0.66x0.11x0.27x-0.51x0.11x0.71x-0.82x
Interest Paid1.77M06.83M6.03M000000000000000000000000
Taxes Paid001.25M680K000000000000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Regulatory reimbursement and integration

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Persistent Divergence Between Earnings Reality

According to the provided financial data, QIPT consistently reports negative net income while generating positive operating cash flow, with the OCF/NI ratio frequently exceeding -8.0, suggesting that non-cash charges like depreciation are masking the underlying lack of true economic profitability in the current business model.

The persistent gap between accounting losses and cash generation indicates that the company relies heavily on non-cash expenses to maintain a positive cash flow profile. Investors should monitor whether this divergence is sustainable or if the high depreciation levels reflect an aging asset base that will eventually require significant reinvestment.

Free Cash Flow Volatility Concerns

As reported in quarterly filings, free cash flow margins have fluctuated significantly from a high of 18.2% in 2023Q4 to a low of 5.6% in 2025Q3, reflecting a lack of predictable cash generation despite the company's focus on recurring revenue streams in the respiratory segment.

The erratic nature of FCF suggests that the company's operational efficiency is highly sensitive to timing differences in collections and capital expenditures. This volatility complicates the valuation of the business, as it remains unclear whether the company can achieve a stable, self-funding growth trajectory.

Capital Intensity and Asset Replacement

Based on the reported figures, capital expenditures as a percentage of revenue have ranged from 1.9% to 6.6% over the last ten quarters, indicating that the company must continuously deploy capital to maintain its rental equipment fleet and support its last-mile logistics infrastructure.

The variability in CapEx suggests that the company may be deferring necessary equipment upgrades during periods of cash pressure. Analysts should investigate whether current spending levels are sufficient to replace the aging respiratory equipment fleet without compromising service quality or patient outcomes.

Working Capital Drag on Liquidity

As evidenced by the quarterly cash flow statements, working capital changes have frequently been a net drain on cash, with a significant $4.0 million outflow in 2026Q1, highlighting the inherent difficulties in managing collections within the complex and fragmented U.S. healthcare reimbursement environment.

The recurring negative impact of working capital on cash flow suggests that the company struggles with the timing of insurance adjudications and accounts receivable management. This inefficiency effectively traps cash in the balance sheet, limiting the company's ability to fund operations internally.

QIPT — Frequently Asked Questions

Quick answers to the most common questions about buying QIPT stock.

How much cash does Quipt Home Medical Corp. (QIPT) generate from operations?

Quipt Home Medical Corp. (QIPT) generated $37.7M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Quipt Home Medical Corp.'s free cash flow?

Quipt Home Medical Corp. (QIPT) generated $25.3M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Quipt Home Medical Corp.'s capital expenditure (CapEx)?

Quipt Home Medical Corp. (QIPT) spent $12.4M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Quipt Home Medical Corp. distribute cash to shareholders?

In 2025, Quipt Home Medical Corp. (QIPT) spent $0.1M on share repurchases. This shows the company's commitment to returning capital to its equity investors.